Search Within

Vincent Miller

Formats
  1. Journal Article (152)
  2. Meeting Abstract (114)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (207)
  2. Solid Tumor Oncology Division (197)
  3. Thoracic Oncology (189)
  4. Department of Pathology and Laboratory Medicine (71)
  5. GSK Faculty (67)
  6. Human Oncology and Pathogenesis Program (64)

More Groups

People
  1. Mark Kris (172)
  2. Gregory Riely (79)
  3. William Pao (65)
  4. Marc Ladanyi (59)
  5. Christopher Azzoli (46)
  6. Maureen Zakowski (46)

More People

Years
  1. 2019 (1)
  2. 2017 (2)
  3. 2016 (1)
  4. 2015 (3)
  5. 2014 (5)
  6. 2013 (4)

More Years

Publications
  1. Journal of Clinical Oncology (80)
  2. Clinical Cancer Research (39)
  3. Journal of Thoracic Oncology (24)
  4. Seminars in Oncology (13)
  5. Cancer (10)
  6. Cancer Chemotherapy and Pharmacology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (57)
  3. Elsevier Inc. (38)
  4. Elsevier Science, Inc. (11)
  5. Springer (10)
  6. Wiley Blackwell (10)

More Publishers

Results (270)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EGFR exon 19 insertions: A new family of sensitizing EGFR mutations in lung adenocarcinoma
    Journal Article

    He, M.; Capelletti, M.; Nafa, K.; Yun, C. H.; Arcila, M. E.; Miller, V. A.; Ginsberg, M. S.; Zhao, B.; Kris, M. G.; Eck, M. J.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • EGFR-mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib
    Journal Article

    Chmielecki, J.; Pietanza, M. C.; Aftab, D.; Shen, R.; Zhao, Z.; Chen, X.; Hutchinson, K.; Viale, A.; Kris, M. G.; Stout, T.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • XL647-A multitargeted tyrosine kinase inhibitor: Results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib
    Journal Article

    Pietanza, M. C.; Lynch, T. J. Jr; Lara, P. N.; Cho, J.; Yanagihara, R. H.; Vrindavanam, N.; Chowhan, N. M.; Gadgeel, S. M.; Pennell, N. A.; Funke, R.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI
    Meeting Abstract

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; Miller, V. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Response to EGFR TKIs in never smokers with stage IV EGFR mutant squamous cell carcinoma of the lung (SQCC)
    Meeting Abstract

    Paik, P. K.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Disease flare after tyrosine kinase inhibitor (TKI) discontinuation in patients with EGFR-mutant lung cancer and acquired resistance
    Meeting Abstract

    Chaft, J. E.; Oxnard, G. R.; Miller, V. A.; Kris, M. G.; Sima, C. S.; Riely, G. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Pulsatile high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
    Journal Article

    Grommes, C.; Oxnard, G. R.; Kris, M. G.; Miller, V. A.; Pao, W.; Holodny, A. I.; Clarke, J. L.; Lassman, A. B.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • A phase 2 study of weekly albumin-bound paclitaxel (Abraxane ®) given as a two-hour infusion
    Journal Article

    Paik, P. K.; James, L. P.; Riely, G. J.; Azzoli, C. G.; Miller, V. A.; Ng, K. K.; Sima, C. S.; Heelan, R. T.; Kris, M. G.; Moore, E.; more...
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • Kidney tubular toxicity of maintenance pemetrexed therapy
    Journal Article

    Glezerman, I. G.; Pietanza, M. C.; Miller, V.; Seshan, S. V.
    American Journal of Kidney Diseases (2011)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save